These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7278789)
1. [Advantages and problems of depot preparations]. Abshagen U; Demmer F Med Klin; 1981 Aug; 76(18):484-90. PubMed ID: 7278789 [No Abstract] [Full Text] [Related]
2. [Differences in the bioavailability of delayed action and standard preparations of calcium antagonists]. Blume H Internist (Berl); 1994 Aug; 35(8):782-3. PubMed ID: 7960558 [No Abstract] [Full Text] [Related]
3. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles. Rajaram L; Roy SK; Skerjanec A Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918 [TBL] [Abstract][Full Text] [Related]
4. [A galenic diclofenac more wisely packaged?. Interview by Dr. T. U. Keil]. Brune K Fortschr Med; 1991 Sep; 109(28):91-2, 95. PubMed ID: 1757058 [No Abstract] [Full Text] [Related]
5. [Bioavailability of 2 different depot formulations with 40 mg of isosorbide dinitrate]. Segre G; Zanolo G; Mondino A; Giachetti C; Silvestri S Fortschr Med; 1981 Dec; 99(47-48):2008-13. PubMed ID: 7327496 [No Abstract] [Full Text] [Related]
6. Striving for standards in bioequivalence assessment: a review. Schulz HU; Steinijans VW Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S1-6. PubMed ID: 1601528 [No Abstract] [Full Text] [Related]
7. [Contalgin and Doltard--2 different morphine depot preparations]. Mikkelsen S Ugeskr Laeger; 1993 Apr; 155(14):1063. PubMed ID: 8497942 [No Abstract] [Full Text] [Related]
12. [Intraocular thrombosis caused by corticoid crystals in depot preparations]. Bahmer F Hautarzt; 1991 Sep; 42(9):594. PubMed ID: 1938416 [No Abstract] [Full Text] [Related]
13. [The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches]. Christrup LL; Jensen NH; Jonsson T; Sjøgren P; Steffansen B Ugeskr Laeger; 2009 Oct; 171(44):3215; author reply 3215. PubMed ID: 19866512 [No Abstract] [Full Text] [Related]
14. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state]. Meyer FP; Banditt P Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817 [TBL] [Abstract][Full Text] [Related]
16. [Use of ethylcellulose as an excipient for delayed action preparations]. Gumma A; Dermanci MA; Bel F Pharm Acta Helv; 1972 Oct; 47(10):577-87. PubMed ID: 4642456 [No Abstract] [Full Text] [Related]
17. [Pharmacokinetics and -dynamics of retard formation of isradipine. Summary of studies]. Hirschberger R Fortschr Med; 1993 Oct; 111(30):481-4. PubMed ID: 8258429 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics. Ereshefsky L; Mascarenas CA J Clin Psychiatry; 2003; 64 Suppl 16():18-23. PubMed ID: 14680415 [TBL] [Abstract][Full Text] [Related]
20. Is depot medication safe in the setting of myopathy? Price JR; Bastiampillai T; Dhillon RS Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801 [No Abstract] [Full Text] [Related] [Next] [New Search]